CT-303

N/A

Report date: 2023/04/05 20:00:19

Base Information

Drug NameCT-303
Drug Alias NameCT-303
ClassificationBiologics
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGC Cell Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGC Cell Corp
Active IndicationsN/A
Inactive IndicationsRespiratory Distress Syndrome, Adult

Other Information

ATC CodeN/A
Related LinksN/A